Related Experiment Videos
Infectious endocarditis due to Yersinia enterocolitica
G Karachalios1, G Bablekos, G Karachaliou
1Department of Medicine, Charing Cross Hospital, Athens, Greece.
Chemotherapy
|July 26, 2002
Summary
Yersinia enterocolitica endocarditis is rare but treatable. Successful treatment involved a combination of ofloxacin and netilmicin, offering hope for this uncommon infection.
Area of Science:
- Microbiology
- Infectious Diseases
- Cardiology
Background:
- Yersinia enterocolitica is a Gram-negative coccobacillus acquired orally.
- While septicemia is increasingly recognized, Y. enterocolitica endocarditis remains a rare clinical manifestation.
- The first documented human infection occurred in 1933.
Observation:
- This report details a rare case of Yersinia enterocolitica endocarditis.
- The patient presented with symptoms indicative of endocardial infection.
Findings:
- Successful treatment of Y. enterocolitica endocarditis was achieved.
- A combination antibiotic regimen including a quinolone (ofloxacin) and an aminoglycoside (netilmicin) was employed.
- This therapeutic approach proved effective in resolving the infection.
Implications:
- This case highlights a viable treatment strategy for rare Yersinia enterocolitica endocarditis.
- The findings suggest that combined quinolone and aminoglycoside therapy can be effective.
- Further research into optimal treatment protocols for this rare condition is warranted.